STERIS Gross Margin 2010-2022 | STE

Current and historical gross margin for STERIS (STE) over the last 10 years. The current gross profit margin for STERIS as of September 30, 2022 is %.
STERIS Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2022-09-30 $4.78B $2.16B 45.22%
2022-06-30 $4.77B $2.11B 44.17%
2022-03-31 $4.59B $2.02B 43.97%
2021-12-31 $4.25B $1.82B 42.94%
2021-09-30 $3.85B $1.63B 42.41%
2021-06-30 $3.41B $1.48B 43.50%
2021-03-31 $3.11B $1.34B 43.21%
2020-12-31 $3.06B $1.33B 43.41%
2020-09-30 $3.02B $1.31B 43.41%
2020-06-30 $3.00B $1.30B 43.32%
2020-03-31 $3.03B $1.32B 43.55%
2019-12-31 $2.98B $1.29B 43.35%
2019-09-30 $2.90B $1.25B 43.00%
2019-06-30 $2.84B $1.21B 42.68%
2019-03-31 $2.78B $1.18B 42.24%
2018-12-31 $2.73B $1.13B 41.50%
2018-09-30 $2.70B $1.12B 41.69%
2018-06-30 $2.65B $1.11B 41.68%
2018-03-31 $2.62B $1.09B 41.68%
2017-12-31 $2.59B $1.08B 41.82%
2017-09-30 $2.57B $1.06B 41.28%
2017-06-30 $2.58B $1.04B 40.40%
2017-03-31 $2.61B $1.03B 39.32%
2016-12-31 $2.62B $1.01B 38.53%
2016-09-30 $2.59B $0.99B 38.18%
2016-06-30 $2.44B $0.95B 39.02%
2016-03-31 $2.24B $0.90B 39.97%
2015-12-31 $2.05B $0.84B 41.15%
2015-09-30 $1.91B $0.80B 42.15%
2015-06-30 $1.88B $0.79B 41.96%
2015-03-31 $1.85B $0.77B 41.82%
2014-12-31 $1.81B $0.75B 41.07%
2014-09-30 $1.75B $0.71B 40.76%
2014-06-30 $1.67B $0.67B 40.35%
2014-03-31 $1.62B $0.65B 40.05%
2013-12-31 $1.59B $0.64B 40.61%
2013-09-30 $1.56B $0.63B 40.58%
2013-06-30 $1.53B $0.63B 41.19%
2013-03-31 $1.50B $0.62B 41.37%
2012-12-31 $1.46B $0.61B 41.49%
2012-09-30 $1.44B $0.59B 41.17%
2012-06-30 $1.43B $0.57B 40.14%
2012-03-31 $1.41B $0.57B 40.37%
2011-12-31 $1.40B $0.56B 40.14%
2011-09-30 $1.37B $0.56B 40.86%
2011-06-30 $1.34B $0.56B 41.96%
2011-03-31 $1.21B $0.45B 36.95%
2010-12-31 $1.16B $0.43B 37.21%
2010-09-30 $1.16B $0.43B 37.38%
2010-06-30 $1.16B $0.43B 37.15%
2010-03-31 $1.26B $0.54B 42.85%
2009-12-31 $1.27B $0.54B 42.28%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $18.026B $4.585B
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $216.198B 22.61
Edwards Lifesciences (EW) United States $47.210B 32.49
Alcon (ALC) Switzerland $33.483B 28.83
Teleflex (TFX) United States $10.579B 17.16
Fresenius Medical Care AG KGaA (FMS) Germany $9.137B 9.17
Penumbra (PEN) United States $7.442B 1781.27
Globus Medical (GMED) United States $7.143B 36.31
Integer Holdings (ITGR) United States $2.386B 19.15
Glaukos (GKOS) United States $2.248B 0.00
Nevro (NVRO) United States $1.572B 0.00
Paragon 28 (FNA) United States $1.556B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.248B 17.77
Artivion (AORT) United States $0.525B 0.00